Improved trends of lung cancer mortality-to-incidence ratios in countries with high healthcare expenditure

doi:10.1111/1759-7714.13912

中山醫學大學機構典藏 CSMUIR > 中山醫學大學研究成果 > 期刊論文 > Item 310902500/23722

Please use this identifier to cite or link to this item: https://ir.csmu.edu.tw:8080/ir/handle/310902500/23722

Title:	Improved trends of lung cancer mortality-to-incidence ratios in countries with high healthcare expenditure
Authors:	Sung, WW;Au, KK;Wu, HR;Yu, CY;Wang, YC
Keywords:	expenditure;incidence;lung cancer;mortality;mortality‐ to‐ incidence ratio
Date:	2021
Issue Date:	2022-08-05T09:41:50Z (UTC)
Publisher:	WILEY
ISSN:	1759-7706
Abstract:	Background Lung cancer stage has a significant impact on prognosis, and early detection of lung cancer relies on screenings. Despite the strong relationship between screening and lung cancer staging, the role of healthcare expenditure in lung cancer outcomes remains unknown. The aim of this study was to evaluate the relationship between economic status and clinical outcomes in lung cancer. Methods Data were obtained from GLOBOCAN and the World Health Organization. Mortality-to-incidence ratios (MIRs) and their change over time, calculated as the difference between the MIRs of 2012 and 2018 (delta MIR), were used to evaluate their correlation to expenditures on healthcare and human development index (HDI) disparities via Spearman's rank correlation coefficient. Results Regions such as North America have relatively high crude incidence rates but low MIR values. Furthermore, countries with lower crude incidence rates spent less on healthcare. The results show significant negative associations between HDI, current health expenditure (CHE) per capita, CHE as a percentage of gross domestic product (CHE/GDP), and MIR. As for MIR and delta MIR, countries with favorable MIRs also showed improving MIRs based on delta MIR. Conclusions HDI, CHE per capita, CHE/GDP, and development status play noticeable roles in the prognosis of lung cancer, leading to large disparities in clinical outcomes.
URI:	http://dx.doi.org/10.1111/1759-7714.13912 https://www.webofscience.com/wos/woscc/full-record/WOS:000637589600001 https://ir.csmu.edu.tw:8080/handle/310902500/23722
Relation:	THORACIC CANCER ,2021,v12,issue 11, P1656-1661
Appears in Collections:	[中山醫學大學研究成果] 期刊論文

Files in This Item:

File	Description	Size	Format
index.html		0Kb	HTML	172	View/Open

Loading...